Zimmer Biomet Holdings (ZBH) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY24 EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to Zimmer Biomet Holdings (ZBH) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY24 EPS Guidance

Zimmer Biomet (ZBH) PT Raised to $117 at Truist Securities

October 31, 2024 12:37 PM EDT

Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $117.00 (from $112.00) while maintaining a Hold rating.

The analyst comments "ZBH's 3Q cc rev beat offset by ~90bps op margin miss; in-line EPS benefited from non-operating items and... More

Oppenheimer Reiterates Outperform Rating on Zimmer Biomet (ZBH)

October 30, 2024 4:28 PM EDT

Oppenheimer analyst Steven Lichtman reiterated an Outperform rating and $135.00 price target on Zimmer Biomet (NYSE: ZBH).

The analyst comments "3Q24 sales of $1.824B (+4.1% constant-currency) outpaced our/Street's $1.791B/$1.795B on less ERP headwind than expected and better than expected underlying performance, particularly in SET. Knees... More